Hit enter to search or ESC to close
Cortexyme
  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers
Cortexyme
Tag

Interim Analysis

EventsPress Release

Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis

By admin | Events, Press Release

Please note our Privacy Policy and Terms of Use. ©2022 Cortexyme

  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers